|
HS Code |
104423 |
| Generic Name | Pravastatin Sodium |
| Brand Names | Pravachol |
| Drug Class | Statin (HMG-CoA reductase inhibitor) |
| Indications | Hyperlipidemia, prevention of cardiovascular disease |
| Route Of Administration | Oral |
| Dosage Forms | Tablets |
| Mechanism Of Action | Inhibits HMG-CoA reductase, reducing cholesterol synthesis |
| Common Side Effects | Headache, nausea, muscle pain |
| Contraindications | Active liver disease, pregnancy, breastfeeding |
| Prescription Status | Prescription only |
| Atc Code | C10AA03 |
| Half Life | 1.8 hours |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
| Metabolism | Hepatic, non-CYP mediated |
| Excretion | Renal and biliary |
As an accredited Pravastatin Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tamper-evident plastic bottle containing 100 tablets of Pravastatin Sodium 20 mg, labeled with batch number and expiration date. |
| Shipping | Pravastatin Sodium should be shipped in tightly sealed containers, protected from moisture and light. During transit, maintain a controlled room temperature (15–30°C). The package must include proper labeling compliant with hazardous material regulations and safety data sheets. Ensure secure packaging to prevent damage or contamination during handling and shipping. |
| Storage | Pravastatin Sodium should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It should be kept in a tightly closed container, protected from moisture, light, and excessive heat. The storage area should be dry and well-ventilated, away from incompatible substances. Keep out of reach of children and unauthorized persons. |
|
Purity 99%: Pravastatin Sodium with 99% purity is used in pharmaceutical formulations, where it ensures consistent lipid-lowering efficacy. Molecular Weight 446.52 g/mol: Pravastatin Sodium at a molecular weight of 446.52 g/mol is used in cardiovascular therapy, where it provides reliable dosing accuracy. Particle Size <10 µm: Pravastatin Sodium with particle size below 10 µm is used in tablet manufacturing, where it promotes uniform drug dispersion and absorption. Melting Point 238°C: Pravastatin Sodium with a melting point of 238°C is used in oral solid dosage forms, where it guarantees thermal stability during processing. Stability Temperature 25°C: Pravastatin Sodium stable at 25°C is used in long-term storage conditions, where it maintains pharmacological potency. Water Solubility 25 mg/mL: Pravastatin Sodium with water solubility of 25 mg/mL is used in liquid formulations, where it enhances ease of drug administration. Residual Solvents <0.5%: Pravastatin Sodium with residual solvents less than 0.5% is used in parenteral applications, where it minimizes toxicity risks. Optical Rotation +24° to +28°: Pravastatin Sodium with optical rotation between +24° and +28° is used in stereoselective therapeutic regimens, where it ensures active enantiomer availability. Heavy Metal Content <10 ppm: Pravastatin Sodium containing less than 10 ppm heavy metals is used in pediatric medicines, where it supports superior safety standards. Assay ≥98%: Pravastatin Sodium assayed at not less than 98% is used in generic drug manufacturing, where it secures regulatory compliance and therapeutic consistency. |
Competitive Pravastatin Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Not every pill makes a dent in the vast world of heart health, but Pravastatin Sodium has done more than just show up in the lineup. With heart disease standing as a top cause of death worldwide, lowering cholesterol isn't just a box doctors check—it's the daily grind for countless people. Pravastatin Sodium, known in pharmacies and clinics for decades, belongs to the statin family. It doesn't just bring down the LDL "bad" cholesterol. It also helps rein in the risk of heart attacks and strokes, which makes it a staple in nearly every cardiologist’s toolkit.
Sometimes medications roll out and cause a stir for a few years, then fade out or make way for newer versions. Pravastatin Sodium sticks around. Registered on the World Health Organization’s List of Essential Medicines, its value goes far beyond brand or marketing trends. Part of that longevity comes from a track record—many studies and real household experience have kept it relevant. In a world full of quick fixes and new pills, trust matters. People settle on pravastatin because it shows up where it counts: reducing cardiac events, holding down cholesterol, and rarely causing trouble with drug interactions.
Every statin has its pros and cons, but not every statin carves out a niche the way pravastatin does. This one gets processed in the liver but doesn’t rough up the metabolic pathways as much as some others do, like atorvastatin or simvastatin. For anyone who’s juggling meds—maybe treating high blood pressure, diabetes, or even infections at the same time—these differences aren’t just details. A lower risk of drug interactions means fewer headaches for both patient and doctor. For older adults, or for people managing multiple prescriptions, that peace of mind makes a difference. It also tends to cause fewer muscle aches, which is a common deal-breaker for many other statins.
The pharmaceutical industry isn’t always easy to trust, but year after year, generic pravastatin keeps its price fair. That’s a big reason why public health programs keep it on formulary lists. With rising healthcare costs and access barriers, a medicine that holds its ground on affordability without losing reliability deserves respect. For community healthcare, that’s no minor detail. People living on fixed incomes, uninsured families, or even entire public health organizations all need medicines that last—and that don’t cost a fortune.
Tablets come in a handful of strengths: 10mg, 20mg, 40mg, and, in some places, 80mg. The real world is rarely one-size-fits-all, especially when it comes to high cholesterol, so having those options matters. Someone starting out with mildly high cholesterol might start at 10mg, while those facing serious heart risks may hit the higher dose. Doctors often adjust doses based on lab results and side effects. Unlike some statins, pravastatin can be taken any time of day, but many still prefer a nightly routine—old habits in medicine die hard.
Some people wonder if it’s all about the numbers—just chase that LDL cholesterol lower and good things will follow. But truth comes in lived experience. Taking pravastatin fits into daily routines. People pop it before bed alongside blood pressure pills, or with dinner, depending on their doctor’s advice. The body processes this statin differently from others—it’s less likely to get tangled up with grapefruit juice or antibiotics the way simvastatin or atorvastatin might. For patients with liver concerns, that ease of use means less anxiety and more control.
Not every cholesterol-lowering drug is interchangeable. There’s a reason why a doctor might pick pravastatin over rosuvastatin, even when both can drive cholesterol down. Atorvastatin works hard, but it pulls double duty through a different metabolic pathway—CYP3A4. That means it sometimes clashes with a whole roster of other prescriptions. Pravastatin’s method steers clear, making it a solid pick for people with complicated medication lists. Doctors who look after older patients, or those who want to avoid surprises, know that sticking with pravastatin often means less drama.
Side effects can also make or break a long-term prescription. Some statins have a reputation for causing muscle pain, sleep disruption, or even memory blips. Pravastatin stands out for its gentle approach. Fewer muscle aches mean better odds that people will stick with it. And over the years, this has proven true in the clinic, not just the lab—people finish the bottle, refill their prescription, and avoid the cycle of quitting and starting over. That kind of adherence pays off, both for the individual and for the whole health system.
Often, people hear about statins causing diabetes in rare cases. Pravastatin has shown a lower tendency for this kind of side effect compared to its cousins. For anyone on the edge of metabolic syndrome, or who’s already watching their blood sugar, that’s one less thing to stress about. Medicine shouldn’t make problems while solving others, and that’s where pravastatin’s gentle hand pays off.
Talk with frontline doctors and you’ll hear familiar stories: patients with a history of heart attacks, sometimes with doubts or side effects from previous meds, come back to try pravastatin. Many stick with it. One family doctor I worked alongside shared how his older patients—those managing diabetes, hypertension, and cholesterol all at once—usually responded better to pravastatin than to other options. He didn’t need to chase down odd lab results or switch medications due to persistent aches and pains. It’s that blend of reliability, safety, and cost that keeps the pharmacy shelves stocked and the prescription pads filled.
Patients chime in, too. Someone who had muscle pain from simvastatin might find relief with pravastatin. A retiree on a fixed income can afford the generic tablets. These stories aren’t just anecdotes; over the years, large studies like the West of Scotland Coronary Prevention Study (WOSCOPS) and PROSPER have shown that pravastatin doesn’t just drop cholesterol—it actually helps people live longer, with fewer heart attacks and strokes.
Big-picture solutions rarely hinge on one pill, but when it comes to dealing with cardiovascular disease on a large scale, pravastatin carries more weight than most medicines. Health organizations and entire countries use it as a go-to for lowering risk across whole populations. The track record matters. For rural clinics, city hospitals, and everything in between, the same rules apply: dependable medicine saves lives and keeps systems rolling. Budget constraints, changing patient needs, and shifting guidelines keep public health planners up at night, but knowing a reliable statin is still on the list helps everyone breathe easier.
Some might overlook the practical details. Ease of access, especially in remote or underfunded health systems, shapes outcomes every day. Pravastatin doesn’t need cold storage or tricky logistics—just a bottle and a routine. For community nurses and field doctors, practicality isn’t just a footnote; it’s the difference between successful intervention and lost opportunity.
From village clinics in Southeast Asia to major urban hospitals in America, pravastatin’s stability on essential medicine lists speaks volumes. Doctors, too, don’t always have rooms full of specialists at their fingertips. General practitioners rely on medicines they trust, and pravastatin has earned its place through solid results rather than marketing or newfangled science.
No drug gets a free pass. Some people still deal with mild side effects: upset stomach, headaches, or a test result here or there that raises eyebrows. Rarely, serious side effects like rhabdomyolysis pop up, though much less often than with stronger statins. Those risks mean doctors and patients need honest conversations. Labs matter. Regular blood tests check liver function and muscle enzymes, making sure small problems don’t become big ones. Patients, for their part, should always speak up about symptoms rather than toughing it out in silence.
Certain folks need extra attention. Anyone with a history of liver issues or kidney trouble might get lower starting doses or different monitoring schedules. Pregnant women or those trying to conceive steer clear of statins altogether. These guardrails aren’t fine print—they’re front and center, and they remind us that even the best medicines fit into a bigger picture of lifestyle changes, diet, exercise, and regular checkups.
With cholesterol management in some ways taking a back seat to new diabetes drugs and innovative therapies, it’s tempting to overlook longtime standbys like pravastatin. But year after year, evidence continues to build. Newer studies keep confirming what many longtime prescribers already know. Older adults see fewer heart attacks and strokes. Hospital admissions drop—and so do costs—for those staying on proven statins.
Industry shifts matter, too. As manufacturing standards improve and more generics hit the market, pravastatin becomes more accessible. It’s now an option in much of the world regardless of local patent rules or drug pricing wars. Insurance programs and state subsidies tend to favor generics, keeping programs flush and household budgets in check. Funds once spent on branded medications find new uses: staff salaries, new equipment, or expanded patient services.
Medicine rarely works in a vacuum. To get the most from pravastatin, patients lean on education. Doctors take time to break down why cholesterol matters, how each statin differs, and what symptoms need watching. Pharmacists step in with advice on timing, possible interactions, and what to avoid. Health systems back it up with reminders, check-ins, and public education campaigns. Access to labs and easy refills can mean the difference between theoretical benefit and real prevention.
For policymakers, making pravastatin affordable and easy to obtain goes deeper than stocking shelves. It means fighting against black market counterfeits, advocating for fair pricing, and supporting research on new uses or better dosage forms. On a practical level, simple packaging, clear labeling, and multilingual instructions help make sure the right person gets the right pill, every time.
Families juggling multiple medications need support networks. For home health aides, community-based nurses, or social workers, keeping patients on pravastatin sometimes means tracking doses and reinforcing routines. Easy-to-open bottles, blister packaging, and daily pill organizers tackle some of the practical problems that come with long-term care for seniors, or for anyone living with memory challenges.
From a practical standpoint, meal habits and routines shape outcomes. Doctors often encourage pairing pravastatin with dinner or setting a phone reminder for bedtime. Small details, like consistency in timing, can amplify results. Encouraging patients to keep a simple record—either in a notebook or through an app—helps flag side effects or missed doses early.
Personal experience, as a clinician and advocate, has shown me the weight of trust in healthcare. People hang their hopes on treatments that don’t just look good on paper, but that also fit the messiness of daily life. Pravastatin Sodium stands as an example of a medicine that meets those messy needs: affordable, available, trusted by clinicians, and easy to work into routines. In the clinic, stories and studies back it up. It’s not flashy, but it works.
Clear communication makes the difference. Patients who understand why they’re taking their medicine, who know what to expect, and who trust their care team, stick with their regimens and see the strongest results. For someone worried about costs, side effects, or drug interactions, pravastatin often feels like the safest bet. From my own experience, both as a provider and from the stories shared by doctors and patients in countless follow-ups, pravastatin earns its place through action, not marketing.
No solution comes without challenges. Adherence, or the ability to keep taking a medication as prescribed, still trips people up. Changes in routine, new diagnoses, moving from one doctor to the next—any of these can cause a slip. Digital reminders, telehealth check-ins, and better community outreach all help, but there’s always room to grow. Health systems that invest in patient education see better results, with more people reaching healthy cholesterol levels and fewer interruptions in their care.
Keeping pravastatin affordable means ongoing vigilance. Regulators, health organizations, and advocacy groups need to watch for sudden price hikes or supply problems. Drawing on large-scale purchase agreements, open access for generics, and transparency in procurement can keep costs down. In every setting—public clinics, private practices, hospitals—policy choices shape patient experience on the ground. Well-supported systems make adherence easier and make good outcomes more likely for everyone.
Through years of use, study, and adjustment, pravastatin sodium stands out as more than just another cholesterol pill. It offers reliability to those who often have the most to lose from missed doses or unpredictable side effects. It’s not just about numbers on a chart or promises in a brochure—it’s about neighbors, parents, and grandparents keeping their health on track, avoiding heart attacks, and living longer, fuller lives. For those who can’t afford gambles or guesswork, pravastatin proves itself every day, in clinics around the world.
Heart disease won’t step aside anytime soon, and managing cholesterol remains a big part of prevention. In choosing between dozens of statin options, many providers and patients stick with what holds up in both the clinic and the community. Through steady results, broad access, and fewer unpleasant surprises, pravastatin sodium keeps its place on the front line, anchoring real-life prevention one tablet at a time.